zopapogene imadenovec (PRGN-2012) / Precigen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zopapogene imadenovec (PRGN-2012) / Precigen
NCT06538480: Confirmatory Study of PRGN-2012 in Patients with RRP

Recruiting
3
42
US
PRGN-2012
Precigen, Inc
Recurrent Respiratory Papillomatosis, Papillomavirus Infection, Papillomaviridae
03/27
03/29
NCT04724980: Adjuvant PRGN-2012 in Adult Patients with Recurrent Respiratory Papillomatosis

Active, not recruiting
1/2
38
US
PRGN-2012
Precigen, Inc, National Cancer Institute (NCI)
Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae
06/24
06/26

Download Options